the symposium provided dramatic evidence of the value of the use of polyamine inhibition via alpha-difluoromethylornithine ( dfmo , eflornithine ) for advances in chemotherapy of trypanosoma brucei gambiense sleeping sickness and pneumocystis carinii pneumonia in acquired immune deficiency syndrome ( aids ) and also for further understanding the metabolic importance of the ubiquitous polyamines in these organisms .
C0002260
eflornithine
C0041228
sleeping sickness